Anthem Biosciences Ltd Share Price

Overview

Anthem Biosciences Ltd share price is currently ₹868.19, up by ₹0.79 (0.09%) from its previous closing price of ₹867.40. The share price has gained 10.83% over the past month and gained 14.69% over the past year. The stock's 52-week low and high are ₹0.00 and ₹895.36, respectively. Anthem Biosciences Ltd has a market capitalisation of ₹ 49,080.00 Cr. The share price was last updated on 25 Aug 2026, 03:54 PM IST.

Anthem Biosciences Ltd
Anthem Biosciences Ltd
ANTHEM
 0.00
 0.79
0.09%
Healthcare
 0.00(%)1D

Updated: 25 Aug 2026, 03:54:07 pm IST

Market Data

Open Price

 877.39

Prev. Close

 867.40
 864.45

Day Low

 888.90

Day High

 0.00

52 Week Low

 895.36

52 Week High

HealthcarePharmaceuticals & Drugs
CategoryLarge Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

84.70

Sector PE

42.03

PB Ratio

16.21

Sector PB

5.82

EPS

10.25

Dividend Yield

0.30

Today's Volume

317.592 K

5 Day Avg. Volume

497.365 K

PEG Ratio

2.77

Market Cap.

₹ 49,080.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

ActionsEx-DateRecord-Date
DividendsFinal Dividend of 100% at ₹2/Share
25-Jun-202626-Jun-2026

Mutual Fund Ownership

Mutual Fund Holder
Jun 26
Shares held
Jul 26
Shares held
HDFC Flexi Cap Fund - Growth83.28 Lac
83.28 Lac
no change
SBI Midcap Fund - Regular Plan - Growth43.18 Lac
43.18 Lac
no change
Axis ELSS Tax Saver Fund - Regular Plan - Growth25.00 Lac
29.22 Lac
(16.87%)
Aditya Birla Sun Life Flexi Cap Fund - Regular Plan - Growth24.50 Lac
24.50 Lac
no change
SBI MNC Fund - Regular Plan - IDCW22.99 Lac
23.20 Lac
(0.91%)

About Anthem Biosciences Ltd 👋

Anthem Biosciences Limited is an India-based contract research, development and manufacturing organization (CRDMO) with fully integrated operations spanning across drug discovery, development and manufacturing. The Company's segments include CRDMO and Speciality Ingredients. The Company helps new and established biotech's and big pharma, develop, optimize and test proteins, monoclonal antibodies, peptides, large molecules, small molecules, toxins and others. In addition to product research and development, it helps test drugs for safety, efficacy (in vitro and in vivo), pre-clinical animal studies in a GLP facility, clone development, antibody drug conjugates, research and development and manufacture of highly potent compounds, flow chemistry-based production and large-scale commercial product manufacture. Its CRDMO Services include Large Molecules, Small Molecules, HPAPI, Peptides, Lipids, ADCs and Oligonucleotides.

News & Events

Frequently Asked Questions

What is the share price of Anthem Biosciences Ltd?

What is the market cap of Anthem Biosciences Ltd?

Should I buy Anthem Biosciences Ltd stock now?

What is the 52 week high and low of Anthem Biosciences Ltd?

Is the Anthem Biosciences Ltd stock good to buy?

Is Anthem Biosciences Ltd a good buy for the long term?

Is Anthem Biosciences Ltd overvalued or undervalued?

What is the PE and PB ratio of Anthem Biosciences Ltd?

Start Now